Structural insights into ACE2 interactions and immune activation of SARS-CoV-2 and its variants: an in-silico study
Description
The initial interaction between COVID-19 and the human body involves the receptor-binding domain (RBD) of the viral spike protein with the angiotensin-converting enzyme 2 (ACE2) receptor. Likewise, the spike protein can engage with immune-related
